SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Blue Jet Healthcare - Quaterly Results

29 Jan 2025 Evaluate
The Top line for the quarter ended December 2024 of Rs. 3183.82 millions up 90.92% from Rs. 1667.60 millions.Net Profit for the quarter ended December 2024 zoomed to 208.27% from Rs. 321.09 millions to Rs. 989.83  millions.Operating profit for the quarter ended December 2024 rose to 1372.55 millions as compared to 613.36 millions of corresponding quarter ended December 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202412 202312 % Var 202412 202312 % Var 202403 202303 % Var
Sales 3183.82 1667.60 90.92 6895.41 5276.53 30.68 7115.98 7209.82 -1.30
Other Income 132.41 67.54 96.05 340.30 200.30 69.90 288.60 239.56 20.47
PBIDT 1372.55 613.36 123.78 2717.93 1961.92 38.53 2580.90 2430.45 6.19
Interest 0.16 0.37 -56.76 0.64 1.28 -50.00 1.61 13.59 -88.15
PBDT 1372.39 515.56 166.19 2717.29 1863.21 45.84 2481.86 2416.86 2.69
Depreciation 47.45 78.55 -39.59 128.42 203.73 -36.97 280.91 250.74 12.03
PBT 1324.94 437.01 203.18 2588.87 1659.48 56.00 2200.95 2166.12 1.61
TAX 335.11 115.92 189.09 637.78 418.48 52.40 563.44 565.84 -0.42
Deferred Tax 10.11 -10.08 -200.30 37.78 -6.02 -727.57 21.44 7.84 173.47
PAT 989.83 321.09 208.27 1951.09 1241.00 57.22 1637.51 1600.28 2.33
Equity 346.93 346.93 0.00 346.93 346.93 0.00 346.93 346.93 0.00
PBIDTM(%) 43.11 36.78 17.21 39.42 37.18 6.01 36.27 33.71 7.59

Blue Jet Healthcare Share Price

402.60 -4.70 (-1.15%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×